299. Cystic fibrosis Clinical trials / Disease details

Clinical trials : 1,696 / Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02444234 (ClinicalTrials.gov)	July 2015	6/5/2015	Pharmacokinetics of Tedizolid Phosphate in Cystic Fibrosis	Steady-State Pharmacokinetics of Tedizolid in Plasma and Sputum of Patients With Cystic Fibrosis	Cystic Fibrosis	Drug: Tedizolid PO;Drug: Tedizolid IV	University of Southern California	Merck Sharp & Dohme Corp.	Completed	18 Years	N/A	All	11	Phase 4	United States
2	EUCTR2011-000130-11-IT (EUCTR)	25/07/2011	05/03/2012	Clinical trials in rare diseases: therapeutic alternative to the use of oral corticosteroids in patients with cystic fibrosis underwent double lung transplantation.	Clinical trials in rare diseases: therapeutic alternative to the use of oral corticosteroids in patients with cystic fibrosis underwent double lung transplantation.	Double lung transplantation in patients with Cystic Fibrosis MedDRA version: 14.1;Level: PT;Classification code 10011763;Term: Cystic fibrosis lung;System Organ Class: 10010331 - Congenital, familial and genetic disorders MedDRA version: 14.1;Classification code 10025127;Term: Lung transplant;System Organ Class: 10042613 - Surgical and medical procedures;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]	Product Name: Dexamethasone sodium phosphate 250 mg/10 ml solution Product Code: NA INN or Proposed INN: Dexamethasone	AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Italy